Home > Insider Trading > Filing (0001140361-16-056911)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1437402	Ardelyx Inc.	ARDX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1611311	P. David Rosenbaum	C/O Ardelyx, Inc. 34175 Ardenwood Blvd, Suite 100 Fremont CA 94555	Svp, Drug Development	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-09-15	2,540	$22.01	23,340	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	77,592	Indirect	See Footnote

Footnotes

This Amendment is filed to correct the account under which the Reporting Person sold the shares. The original filing reported a sale from the Reporting Person's trust whereas the transaction was executed using shares held in his individual account. All other information, including sale price and number of shares sold, was correct as originally reported.
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 18, 2015.
This transaction was executed in multiple trades in prices ranging from $22.00 to $22.11, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.